Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Relmada Therapeutics Provides Regulatory Update Confirming FDA Alignment on Registrational Studies Design for NDV-01 for Two Separate Indications
-
Tessera Therapeutics Announces FDA Clearance of IND Application for its Lead In Vivo Gene Editing Program TSRA-196 for AATD
-
Golden Arrow Confirms Near-Surface Gold Zone with Trench Results including 76.7m @ 1.01 g/t Au at Noemi Gold Target, San Pietro Project, Chile
-
GTCR Completes Sale of Worldpay to Global Payments
-
Accredant Capital Advises Segue Sustainable Infrastructure on Sale of Community Solar Portfolio to Radial Power
-
A2Z Cust2Mate Expands into Toy Retail with Large-Scale Smart Cart Deployments
-
BioCryst Announces Preliminary Full Year 2025 ORLADEYO® (berotralstat) Net Revenue of $601 Million (+37 percent y-o-y), Beating Prior Guidance Range
-
Avista-Backed WellSpring Consumer Healthcare Acquires Established OTC Skincare Brands, DerMend® and Recticare®
-
NEXT with Michael Sonnenfeldt Returns for Season 2, Featuring Visionary Entrepreneurs Shaping What Comes Next
-
Zumiez Inc. Reports Holiday 2025 Sales Results
-
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update
-
Noodles & Company Announces Preliminary Revenue Results for the Fourth Quarter of 2025
-
Brookdale Reports December 2025 Occupancy
-
ARTBIO Announces Dosing of Two Cohorts with AB001 in ARTISAN, a Phase 1 Alpha Radioligand Therapy Clinical Trial for Metastatic Castration Resistant Prostate Cancer
-
Emerita Resources Provides Corporate Update
-
Waystar Introduces Agentic AI to Advance Toward the Autonomous Revenue Cycle
-
TGI Fridays Unveils Bold Vision to Become Global Casual Dining Leader
-
Skye Provides 2026 Corporate Outlook
-
Protara Therapeutics Highlights Recent Updates and Anticipated 2026 Milestones
-
EDETEK to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation
-
New 2026 ezPaycheck Supports the One Big Beautiful Bill!
-
Lexeo Therapeutics Announces Positive Interim Phase I/II Data for LX2020 for the Treatment of PKP2-Associated Arrhythmogenic Cardiomyopathy
-
Karyopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026
-
Highwoods Announces Investment Activity
-
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan
-
Lilac and Traxys Announce Binding 10-Year Offtake Agreement for Great Salt Lake Lithium Production
-
MindMed Rebrands to Definium Therapeutics, Advancing a Leading Late-Stage Psychiatry Pipeline with Three Phase 3 Readouts Expected in 2026
-
Surya Oil & Gas Corp. Appoints CFO as Company Enters Execution Phase Across West Virginia and Texas
-
Scholar Rock Highlights 2026 Strategic Priorities
-
Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update
-
Henry Schein Names Frederick M. Lowery as Chief Executive Officer
-
Corero Network Security Delivers Strong Full-Year 2025 Performance Driven by Global Customer Wins and Expanding Enterprise Adoption
-
Ferring Pharmaceuticals and Theralase® Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer
-
Global Payments Completes Acquisition of Worldpay and Divestiture of Issuer Solutions Business, Creating Leading Pure-Play Commerce Solutions Provider
-
New Independent Studies: Medicare Advantage Delivers Greater Value to the Federal Government and Beneficiaries than Traditional Medicare
-
Palladyne AI Announces Commercial Availability of Palladyne IQ 2.0, Delivering Industrial Autonomy to Accelerate Defense-Industrial Modernization, Agility, and Throughput
-
TriSalus Life Sciences Announces Preliminary Fourth Quarter and Full-Year 2025 Results and 2026 Revenue Guidance
-
Doseology Engages McKinney Regulatory Science Advisors to Advance Innovative Oral Pouch Product Development through Science and Regulatory Expertise
-
NewcelX Announce Positive Results from International Collaborative Study Exploring Advanced Biomaterial Approaches for Stem Cell-Derived Islet Delivery in Type 1 Diabetes Without Immune Suppression
-
BioXcel Therapeutics Expands Leadership Team to Prepare for Launch of IGALMI® in the At-Home Setting
-
Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
-
Viking Therapeutics Announces Publication of Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in the Journal Obesity
-
FIS Completes Strategic Acquisition of Global Payments’ Issuer Solutions Business and Sale of Worldpay Stake
-
AZIO receives $100 Million worth of Government Purchase Orders, Advances $200 Million Regional Pipeline and Scalable U.S. AI Infrastructure Expansion
-
AN2 Therapeutics Announces FDA Clearance to Proceed with 90-Patient Investigator-Initiated Trial (IIT) of Epetraborole in Patients with M. abscessus Lung Disease
-
Sable Announces Director Change
-
Ionis well-positioned for continued momentum and substantial value creation in 2026 with two new independent launches and several pivotal data readouts
-
Neurolief receives FDA PMA Approval for First At-Home Brain Neuromodulation Therapy for Adults Whose Depression Was Not Adequately Improved by Antidepressants
-
Utz Brands, Inc. Announces Preliminary Fourth Quarter and Fiscal Year 2025 Results
